News

BioM's articles and press releases about the Bavarian biotechnology sector


BIO International 2025: Secure your spot at the German pavilion!

The BIO In­ter­na­tion­al Con­ven­tion will take place from June 16 to 19, 2025 in Bo­ston (USA). With around 20,000 par­ti­cipants, the…

TUM researchers want to stop Alzheimer's at an early stage

In the fight against Alzheimer's, re­search­ers at the Tech­nic­al University of Mu­nich (TUM) have de­veloped a prom­ising, pre­vent­at­ive…

Join the VITAL Biotech Accelerator & Funding Award Programs!

Are you a star­tup or uni­ver­sity-based pro­ject pi­on­eer­ing the fu­ture of thera­peut­ics and vac­cines? BARDA is look­ing for…

BioRN Annual Conference 2024 - 15% discount for our community

We are happy to offer our net­work 15% dis­count for the BioRN An­nu­al Con­fer­ence 2024 on Octo­ber 9 in Heidel­berg. The BAC 2024…

leon-nanodrugs secures financing to expand its portfolio

The Martin­sried-based com­pany leon-nan­od­rugs, which spe­cial­izes in nano-en­cap­su­la­tion sys­tems, has com­pleted a Ser­ies D…

LMU researcher receives million-euro funding for new approaches against acute myeloid leukemia

Prof. Irmela Jeremi­as from the Dr. von Hau­ner Chil­dren's Hos­pit­al at LMU Mu­nich has re­ceived a Rein­hart Kosel­leck grant of 1.25…

Biotech Summit Austria 2024: Connect with industry and partners in Innsbruck! Save your 20% BioM discount!

For its second edi­tion, the BIOTECH SUMMIT AUSTRIA fea­tures again an en­rich­ing face-to-face ex­per­i­ence, and we're thrilled to be part…

BIO-Europe 2024: Early bird rate expires on 26 July! Get the 15% BioM discount. Register now!

This fall, BIO-Europe re­turns for an en­rich­ing face-to-face ex­per­i­ence, and we're thrilled to be part of it! Join BioM from 4 - 6…

Record financing in Martinsried: CatalYm secures 150 million US dollars for breakthrough in cancer treatment

CatalYm has closed a USD 150 mil­lion Ser­ies D fin­an­cing round to ad­vance the fur­ther de­vel­op­ment of its Visu­gromab an­ti­body. The…

SciRhom secures EUR 63 million in Series A financing round for antibody therapy against autoimmune diseases

Martin­sried-based start-up SciRhom has raised €63 mil­lion in a Ser­ies A fin­an­cing round to ad­vance its iRhom2-tar­geted an­ti­body…

Newsletter

Subscribe

Archive



Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager